PL2346841T3 - Kwasy 2-arylopropionowe i pochodne oraz zawierające je kompozycje farmaceutyczne - Google Patents

Kwasy 2-arylopropionowe i pochodne oraz zawierające je kompozycje farmaceutyczne

Info

Publication number
PL2346841T3
PL2346841T3 PL09783167T PL09783167T PL2346841T3 PL 2346841 T3 PL2346841 T3 PL 2346841T3 PL 09783167 T PL09783167 T PL 09783167T PL 09783167 T PL09783167 T PL 09783167T PL 2346841 T3 PL2346841 T3 PL 2346841T3
Authority
PL
Poland
Prior art keywords
aryl
derivatives
pharmaceutical compositions
compositions containing
propionic acids
Prior art date
Application number
PL09783167T
Other languages
English (en)
Polish (pl)
Inventor
Marcello Allegretti
Andrea Aramini
Gianluca Bianchini
Maria Candida Cesta
Original Assignee
Dompe Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Farm Spa filed Critical Dompe Farm Spa
Publication of PL2346841T3 publication Critical patent/PL2346841T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL09783167T 2008-09-18 2009-09-18 Kwasy 2-arylopropionowe i pochodne oraz zawierające je kompozycje farmaceutyczne PL2346841T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08164605A EP2166006A1 (en) 2008-09-18 2008-09-18 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
EP09783167.1A EP2346841B1 (en) 2008-09-18 2009-09-18 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
PCT/EP2009/062109 WO2010031835A2 (en) 2008-09-18 2009-09-18 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
PL2346841T3 true PL2346841T3 (pl) 2015-07-31

Family

ID=40291117

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09783167T PL2346841T3 (pl) 2008-09-18 2009-09-18 Kwasy 2-arylopropionowe i pochodne oraz zawierające je kompozycje farmaceutyczne

Country Status (17)

Country Link
US (1) US8624036B2 (OSRAM)
EP (2) EP2166006A1 (OSRAM)
JP (1) JP5571669B2 (OSRAM)
CN (1) CN102159558B (OSRAM)
AU (1) AU2009294558B2 (OSRAM)
CA (1) CA2737099C (OSRAM)
CY (1) CY1116176T1 (OSRAM)
DK (1) DK2346841T3 (OSRAM)
ES (1) ES2534634T3 (OSRAM)
HR (1) HRP20150395T1 (OSRAM)
IL (1) IL211683A (OSRAM)
PL (1) PL2346841T3 (OSRAM)
PT (1) PT2346841E (OSRAM)
RU (1) RU2520212C2 (OSRAM)
SI (1) SI2346841T1 (OSRAM)
SM (1) SMT201500098B (OSRAM)
WO (1) WO2010031835A2 (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130231340A1 (en) 2012-03-02 2013-09-05 Sareum Limited Pharmaceutical compounds
US10046002B2 (en) 2013-08-02 2018-08-14 Syntrix Biosystems Inc. Method for treating cancer using chemokine antagonists
US10561676B2 (en) * 2013-08-02 2020-02-18 Syntrix Biosystems Inc. Method for treating cancer using dual antagonists of CXCR1 and CXCR2
KR102191084B1 (ko) * 2013-09-03 2020-12-15 사름 리미티드 약제학적 화합물
AR103399A1 (es) * 2015-01-15 2017-05-10 Actelion Pharmaceuticals Ltd Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3
EP3117835A1 (en) * 2015-07-14 2017-01-18 Dompé farmaceutici s.p.a. Il-8 inhibitors for use in the treatment of certain urological disorders
AU2017207850B2 (en) 2016-01-15 2022-06-30 Dompe' Farmaceutici S.P.A. IL-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathy
EP3192504A1 (en) 2016-01-15 2017-07-19 Dompé farmaceutici S.p.A. Il-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathy
US11291641B2 (en) 2016-10-03 2022-04-05 The Children's Medical Center Corporation Prevention and treatment of diabetic nephropathy
GB201617871D0 (en) 2016-10-21 2016-12-07 Sareum Limited Pharmaceutical compounds
US10660909B2 (en) 2016-11-17 2020-05-26 Syntrix Biosystems Inc. Method for treating cancer using chemokine antagonists
EP3342407A1 (en) * 2017-01-03 2018-07-04 Dompé farmaceutici S.p.A. Il-8 inihibitors for use in the treatment of some urological disorders
EP3409277A1 (en) * 2017-05-30 2018-12-05 Dompé farmaceutici s.p.a. Il-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections
EP3476390A1 (en) * 2017-10-24 2019-05-01 Dompé farmaceutici S.p.A. Il-8 inhibitors for use in the treatment of sarcomas
WO2019165315A1 (en) 2018-02-23 2019-08-29 Syntrix Biosystems Inc. Method for treating cancer using chemokine antagonists alone or in combination
GB201816369D0 (en) 2018-10-08 2018-11-28 Sareum Ltd Pharmaceutical compounds
EP3868368A1 (en) 2020-02-21 2021-08-25 Dompe' Farmaceutici S.P.A. Cxcl8 (interleukin-8) activity inhibitor and corticosteroid combination and pharmaceutical composition and use thereof
EP3868369A1 (en) 2020-02-21 2021-08-25 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of cancer-related fatigue
EP3884932A1 (en) 2020-03-26 2021-09-29 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19
EP4125848A1 (en) 2020-03-26 2023-02-08 Dompe' Farmaceutici SpA Cxcl8 inhibitors for use in the treatment of covid-19
EP4008325A1 (en) 2020-12-02 2022-06-08 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19
EP3907214A1 (en) * 2020-05-04 2021-11-10 Dompe' Farmaceutici S.P.A. Co-crystal of ketoprofen, lysine and gabapentin, pharmaceutical compositions and their medical use
US20240115527A1 (en) 2020-11-05 2024-04-11 Icahn School Of Medicine At Mount Sinai Cxcr1/cxcr2 inhibitors for use in treating myelofibrosis
EP4052702A1 (en) 2021-03-04 2022-09-07 Dompé farmaceutici S.p.a. Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of seizures
EP4397305A1 (en) 2023-01-05 2024-07-10 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of ocular mucous membrane pemphigoid and/or oral mucous membrane pemphigoid
EP4406942A1 (en) * 2023-01-26 2024-07-31 Dompe' Farmaceutici S.P.A. Stable monohydrate of df2755a and process for its preparation
EP4563594A1 (en) 2023-11-28 2025-06-04 Dompe' Farmaceutici SpA Cxcl8 inhibitors for use in the treatment of tumors with low stromal cav1 levels

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4025528A (en) * 1973-10-24 1977-05-24 Shionogi & Co., Ltd. Thiazole derivatives of benzoic and phenylalkanoic acids
JPS5537556B2 (OSRAM) * 1973-12-27 1980-09-29
CA1051906A (en) * 1973-10-24 1979-04-03 Shionogi And Co. Thiazole derivatives and production thereof
JPS565747B2 (OSRAM) * 1973-10-24 1981-02-06
JPS5629871B2 (OSRAM) * 1974-05-22 1981-07-10
JPS62142168A (ja) * 1985-10-16 1987-06-25 Mitsubishi Chem Ind Ltd チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤
IT1298214B1 (it) 1998-01-28 1999-12-20 Dompe Spa Sali dell'acido (r) 2-(3-benzoilfenil) propionico e loro composizioni farmaceutiche.
IT1303249B1 (it) * 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
IT1317826B1 (it) * 2000-02-11 2003-07-15 Dompe Spa Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8.
ITMI20012434A1 (it) 2001-11-20 2003-05-20 Dompe Spa Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono
EP1467981A1 (en) * 2002-01-25 2004-10-20 Kylix Pharmaceuticals B.V. 4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2
ATE444286T1 (de) * 2004-03-23 2009-10-15 Dompe Pha R Ma Spa Res & Mfg 2-phenylpropionsäurederivate und diese enthaltende pharmazeutische zusammensetzung
US8026367B2 (en) * 2005-11-24 2011-09-27 Dompe Pha.R.Ma S.P.A. (R)-arylalkylamino derivatives and pharmaceutical compositions containing them
CN101448784B (zh) * 2006-05-18 2012-07-04 冬姆佩股份公司 (2r)-2-[(4-磺酰基)氨基苯基]丙酰胺及含有它们的药物组合物
ES2394641T3 (es) * 2006-12-19 2013-02-04 Dompe' S.P.A. Ácidos 2-aril-2-fluoropropanoicos y derivados y composiciones farmacéuticas que los contienen
EP2201006B1 (en) * 2007-10-18 2011-03-09 Dompé S.p.a. (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP2346841B1 (en) 2015-01-14
WO2010031835A3 (en) 2010-06-24
RU2520212C2 (ru) 2014-06-20
WO2010031835A2 (en) 2010-03-25
AU2009294558A1 (en) 2010-03-25
SMT201500098B (it) 2015-07-09
CA2737099A1 (en) 2010-03-25
AU2009294558B2 (en) 2014-12-18
JP5571669B2 (ja) 2014-08-13
CN102159558A (zh) 2011-08-17
JP2012502957A (ja) 2012-02-02
RU2011114992A (ru) 2012-10-27
PT2346841E (pt) 2015-05-07
IL211683A0 (en) 2011-06-30
US8624036B2 (en) 2014-01-07
HRP20150395T1 (hr) 2015-06-19
CA2737099C (en) 2016-07-05
EP2346841A2 (en) 2011-07-27
US20110207785A1 (en) 2011-08-25
DK2346841T3 (en) 2015-04-20
CN102159558B (zh) 2015-01-07
ES2534634T3 (es) 2015-04-27
IL211683A (en) 2014-01-30
BRPI0918759A2 (pt) 2015-12-29
SI2346841T1 (sl) 2015-07-31
EP2166006A1 (en) 2010-03-24
CY1116176T1 (el) 2017-02-08

Similar Documents

Publication Publication Date Title
IL211683A0 (en) 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
HUS1800043I1 (hu) 514 számú gyógyszerkészítmény
IL217912A (en) History of 5-Amino-1-Benzimidazole-Pyrazole and Pharmaceutical Preparations Containing It
IL206594A (en) The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations
IL199853A (en) Converged history of 5-Hydroxy-Admentil-2-Reindeer and Pharmaceutical Preparation containing them
IL215497A0 (en) Oxadiazile derivatives and pharmaceutical compositions containing them
IL214175A (en) Derivatives of aminotetralin, their pharmaceutical compositions and their use
IL205043A (en) Phenylamide and pyridylamide derivatives, pharmaceutical preparations containing them, method of preparation and use thereof
ZA201106299B (en) Composition comprising caftaric acid and/or derivatives thereof
IL210446A (en) History of fibrin and medicinal preparations containing them
IL218232A (en) Innaone derivative and a pharmaceutical preparation containing it
EP2277861A4 (en) CYCLIC AMIN-1-CARBOXYLIC ACID EST DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREWITH
ZA201204619B (en) Pharmaceutical composition comprising vitamin d analogue and cosolventsurfactant mixture
PT2320739T (pt) Composições farmacêuticas e métodos para estabilizar as mesmas
IL216462A (en) Pharmaceuticals containing nitrile history and uses
IL207423A0 (en) Amide derivative and pharmaceutical composition containing the same
PT2484661T (pt) Derivado de 2,3-di-hidro-1h-inden-2-il-ureia e sua aplicação farmacêutica
IL207287A0 (en) Amino acid derivatives uses as pharmaceutical substances
ZA201005316B (en) 2-amino-2-phenyl-alkanol derivatives, their preparation and pharmaceutical compositions containing them
TWI365071B (en) Isoxazole derivatives and pharmaceutical compositions comprising the same
ZA201200165B (en) 2-amino-2phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same
HK1168781A (en) Nitrile derivatives and their pharmaceutical use and compositions
HK1164739A (en) Pharmaceutical compositions and solid forms
AU2008903115A0 (en) Pharmaceutical Formulation
GB0805292D0 (en) Pharmaceutical formulation